JP2024544393A - 薬学的眼用組成物およびその使用 - Google Patents

薬学的眼用組成物およびその使用 Download PDF

Info

Publication number
JP2024544393A
JP2024544393A JP2024535940A JP2024535940A JP2024544393A JP 2024544393 A JP2024544393 A JP 2024544393A JP 2024535940 A JP2024535940 A JP 2024535940A JP 2024535940 A JP2024535940 A JP 2024535940A JP 2024544393 A JP2024544393 A JP 2024544393A
Authority
JP
Japan
Prior art keywords
ophthalmic composition
pharmaceutical ophthalmic
approximately
pharmaceutical
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544393A5 (enExample
Inventor
アンジャリ ジョシ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aerie Pharmaceuticals Inc
Original Assignee
Aerie Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aerie Pharmaceuticals Inc filed Critical Aerie Pharmaceuticals Inc
Publication of JP2024544393A publication Critical patent/JP2024544393A/ja
Publication of JP2024544393A5 publication Critical patent/JP2024544393A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2024535940A 2021-12-17 2022-12-16 薬学的眼用組成物およびその使用 Pending JP2024544393A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163290781P 2021-12-17 2021-12-17
US63/290,781 2021-12-17
PCT/US2022/081775 WO2023114986A1 (en) 2021-12-17 2022-12-16 Ophthalmic pharmaceutical compositions and uses thereof

Publications (2)

Publication Number Publication Date
JP2024544393A true JP2024544393A (ja) 2024-11-29
JP2024544393A5 JP2024544393A5 (enExample) 2025-11-10

Family

ID=85157426

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535940A Pending JP2024544393A (ja) 2021-12-17 2022-12-16 薬学的眼用組成物およびその使用

Country Status (10)

Country Link
US (3) US11850221B2 (enExample)
EP (1) EP4447935A1 (enExample)
JP (1) JP2024544393A (enExample)
KR (1) KR20240121320A (enExample)
CN (1) CN118076340A (enExample)
AU (2) AU2022409839B2 (enExample)
CA (1) CA3242833A1 (enExample)
IL (1) IL313616A (enExample)
MX (1) MX2024007092A (enExample)
WO (1) WO2023114986A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3242833A1 (en) 2021-12-17 2023-06-22 Alcon Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND THEIR USES
US20250384550A1 (en) * 2023-06-09 2025-12-18 Chung Shan Medical University Reagent and kit for identifying and diagnosis ocular surface disease (osd) and use thereof
US20260027050A1 (en) * 2024-07-23 2026-01-29 Alcon Inc. Acoltremon combinations and uses thereof
WO2026154426A1 (en) * 2025-01-16 2026-07-23 Alcon Inc. Ophthalmic pharmaceutical compositions and uses thereof

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1067684A (ja) 1996-06-17 1998-03-10 Mitsubishi Chem Corp 涙液分泌促進剤
JPH10236972A (ja) 1997-02-28 1998-09-08 Mitsubishi Chem Corp 涙液分泌促進剤
JP3142842B1 (ja) 1999-10-22 2001-03-07 ライオン株式会社 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
US6569903B2 (en) 1999-12-07 2003-05-27 Rohto Pharmaceutical Co., Ltd. Ophthalmic compositions
US20020009507A1 (en) 2000-01-19 2002-01-24 Alcon Universal Ltd. Use of polyethoxylated castor oil for the treatment of dry eye
AU2003210663A1 (en) 2002-01-25 2003-09-02 The Regents Of The University Of California Methods of modulating cold sensory perception
US20060084684A1 (en) 2002-05-28 2006-04-20 Altana Pharma Ag Topically applicable pharmaceutical preparation
US6919348B2 (en) 2002-05-02 2005-07-19 Edward T. Wei Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
DE10259619A1 (de) 2002-12-18 2004-07-08 Metagen Pharmaceuticals Gmbh Verwendung einer TRPM8 aktivierenden Substanz zur Tumorbehandlung
CA2530884C (en) 2003-07-02 2016-01-12 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
US20050137166A1 (en) 2003-12-19 2005-06-23 Alcon, Inc. Use of cooling agents to relieve mild ocular irritation and enhance comfort
EP1802600A1 (en) 2004-10-13 2007-07-04 Bayer HealthCare AG Substituted 4-benzyloxy-phenylmethylamide derivatives as cold menthol receptor-1 (cmr-1) antagonits for the treatment of urological disorders
US20060111388A1 (en) 2004-11-19 2006-05-25 University Of North Texas Health Science Center At Fort Worth Phenanthroline and derivatives thereof used to lower intraocular pressure in an affected eye
JP5078254B2 (ja) 2004-12-17 2012-11-21 ロート製薬株式会社 眼科用組成物
GB0504194D0 (en) 2005-03-02 2005-04-06 Givaudan Sa Organic compounds
WO2007017092A1 (en) 2005-08-04 2007-02-15 Bayer Healthcare Ag Substituted 4-benzyloxy-benzoic acid amide derivatives
US7727516B2 (en) 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
CN101405009B (zh) 2006-03-23 2011-04-13 千寿制药株式会社 包含黄原胶和葡萄糖的眼科组合物
US7887859B2 (en) 2006-11-02 2011-02-15 Riolan Technologies, Inc. Methods of treating epiphora
GB2451503B (en) 2007-08-01 2011-10-12 Lrc Products Stimulating gel comprising a cyclic carboxamide coolant
FR2934778B1 (fr) 2008-08-11 2012-09-28 Natura Cosmeticos Sa Compositions d'anti-transpirants et procedes permettant de reduire la transpiration chez les humains
US8653099B2 (en) 2008-08-19 2014-02-18 Janssen Pharmaceutica Cold menthol receptor antagonists
ES2377785B2 (es) * 2010-09-08 2012-09-26 Universidad Miguel Hernández De Elche Composición farmacéutica para el tratamiento del ojo seco.
KR102073258B1 (ko) 2014-04-15 2020-02-04 비쭈리 헬스 사이언스 엘엘씨 통증 완화용 국소 조성물, 제조방법 및 용도
ES2625393A1 (es) 2016-01-19 2017-07-19 Universidad Miguel Hernandez De Elche Compuestos agonistas del receptor trpm8 y sus aplicaciones
US20180252700A1 (en) 2016-10-06 2018-09-06 Ora, Inc. Screening agents in dry eye disease
US20220080048A1 (en) * 2016-10-12 2022-03-17 PS Therapy Ltd Opthalmological compositions and methods of use thereof
CN110996904A (zh) 2017-05-19 2020-04-10 奥古根有限公司 眼用组合物及使用方法
EP3705114A1 (en) 2019-03-06 2020-09-09 Avizorex Pharma, S.L. Ophthalmic composition for treating dry eye and symptoms thereof
WO2021195256A1 (en) 2020-03-24 2021-09-30 Aerie Pharmaceuticals, Inc. Pharmaceutical preparation
CA3242833A1 (en) 2021-12-17 2023-06-22 Alcon Inc. OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND THEIR USES

Also Published As

Publication number Publication date
EP4447935A1 (en) 2024-10-23
IL313616A (en) 2024-08-01
AU2022409839B2 (en) 2025-12-11
US12336971B2 (en) 2025-06-24
MX2024007092A (es) 2024-06-26
CN118076340A (zh) 2024-05-24
US20230233493A1 (en) 2023-07-27
WO2023114986A1 (en) 2023-06-22
AU2026201834A1 (en) 2026-04-02
CA3242833A1 (en) 2023-06-22
US20250281434A1 (en) 2025-09-11
US20240091179A1 (en) 2024-03-21
KR20240121320A (ko) 2024-08-08
AU2022409839A1 (en) 2024-07-11
US11850221B2 (en) 2023-12-26

Similar Documents

Publication Publication Date Title
US12336971B2 (en) Ophthalmic pharmaceutical compositions and uses thereof
US8969385B2 (en) Ocular formulations of norketotifen
AU2010320870B2 (en) Use of prostaglandins F2alpha and analogues for the healing of corneal and conjunctival lesions
CN108175778B (zh) 用于治疗干眼病的组合物
US10172852B2 (en) Method of increasing bioavailability and/or prolonging ophthalmic action of a drug
US20120095097A1 (en) Ophthalmic composition
US20200306218A1 (en) Ophthalmic composition for treating dry eye and symptoms thereof
JP5722802B2 (ja) プロスタグランジンを含有するアニオン性水中油型エマルジョンおよびその使用
US20210085603A1 (en) Microemulsion for opthalmic drug delivery
JP2015071553A (ja) 異物感緩和点眼剤
CN111888326B (zh) 羟甲唑啉组合物和用于治疗眼障碍的方法
JP2025159201A (ja) 眼科組成物
JP7599838B2 (ja) エピナスチン又はその塩を含有する水性医薬組成物
JP2023530189A (ja) 高眼圧症および緑内障の治療および予防のためのヒアルロン酸に基づく製剤
ES2453472T3 (es) Emulsiones catiónicas de aceite en agua que contienen prostaglandinas y usos de estas
GR1009419B (el) Οφθαλμικο φαρμακευτικο σκευασμα που περιεχει εναν συνδυασμο βρινζολαμιδης και βριμονιδινης και μεθοδος για την παρασκευη αυτου
US20240165147A1 (en) Methods for Treating Eyetear Film Deficiency
KR102268002B1 (ko) 효과 지속성 점안제 조성물
US20230149337A1 (en) Ophthalmic formulation and its use
JP6607976B2 (ja) 異物感緩和点眼剤
CN103202833A (zh) 一种奥洛他定或其盐的药用组合物及其制备方法
JP2019218369A (ja) 異物感緩和点眼剤
CN121263183A (zh) 吡美莫司用于治疗患者的特征在于牛津分级量表角膜染色评分为4或5分的干眼症的用途
TR201603016A1 (tr) Poli̇mer i̇çeren oftalmi̇k farmasöti̇k bi̇leşi̇mler
TR201603173A1 (tr) Oftalmi̇k farmasöti̇k bi̇leşi̇mler

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20241107

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251029

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20251029

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260807